#United States #Sacramento #iCRYO #Pico IV #CBD Infusions

New Partnership in CBD IV Therapy

In an exciting development for the wellness sector, Pico IV has officially partnered with iCRYO, a major player in health, wellness, and recovery services across the United States. The partnership aims to bring CBD IV infusion therapies to a wider audience, enhancing accessibility and promoting the acceptance of CBD in healthcare.

A Milestone in Wellness Treatment

Pico IV, known for pioneering advanced CBD-infused hydration therapies, announced this collaboration to merge their innovative IV treatments with iCRYO's extensive network of wellness centers. Joe Young, CEO of Pico IV, expressed his enthusiasm, stating, "This collaboration will introduce the incredible benefits of CBD to new users and make it more accessible than ever."

The Impact of CBD IV Therapy

Cannabidiol (CBD) has gained traction for its potential health benefits, particularly in pain management and emotional well-being. By integrating CBD with IV therapy, users can experience a direct and efficient method of absorbing the compound into the bloodstream, resulting in heightened effectiveness compared to traditional forms of consumption.

Since its launch in August 2023, Pico IV's CBD IV therapy has tapped into the growing demand for holistic wellness solutions. Users have reported significant improvements in their overall health, lending credence to the therapy's efficacy. As Kyle Jones, CEO of iCRYO, pointed out, adding CBD infusions is a vital step toward offering a more comprehensive suite of wellness services. "We strive to offer the best treatments the wellness industry has to provide," he said.

Building a Network for Wellness

The partnership will enable Pico IV's CBD-infused hydration therapies to be available in participating iCRYO centers across the U.S. and Canada. iCRYO, with its rapid expansion, currently operates 50 franchise locations, with hundreds more in various stages of development. The inclusion of CBD-infused IV therapy will not only enhance service offerings but also educate customers about the benefits of cannabinoid-based products.

The recent legislative shifts and consumer interest towards natural remedies spotlight the growing demand for CBD treatments. With this partnership, both companies aim to normalize the use of cannabinoid wellness products in mainstream healthcare, further validated by rigorous third-party testing conducted by Pico IV to ensure product safety and potency.

Future Prospects

As patient demand continues to shift toward alternative treatments, the integration of CBD into IV therapy signifies a promising future for cannabinoid approaches in healthcare. The collaboration between Pico IV and iCRYO marks just the beginning of this evolution, allowing customers to explore holistic wellness options related to CBD IV therapy.

For those interested in discovering the benefits of CBD IV therapy, Pico IV's website offers comprehensive information and a locator feature for nearby iCRYO locations. This partnership is set to redefine health and wellness journeys for many, enabling greater accessibility to innovative therapies.

About Pico IV
Pico IV is a trailblazer in the realm of advanced IV hydration therapies, focusing on enhancing wellness, optimizing health performance, and supporting recovery amidst increasing consumer demands.

About iCRYO
Founded in Houston, Texas, iCRYO strives to provide affordable and professional personal health services while establishing itself as a global leader in the wellness sector. With a wide variety of services that include cryotherapy and now CBD IV infusions, iCRYO is committed to elevating the quality of life for all its clients.